IRIX Pharmaceuticals, Inc.

IRIX Pharmaceuticals, Inc. is a privately held company engaged in the generation of process technology for new and existing drugs.

IRIX also offers the capability to produce pharmaceutical active ingredients (PAI) for pre-clinical and clinical studies.

Formed to provide the Pharmaceutical industry with a low cost alternative for bringing new drugs to market rapidly, IRIX has established a series of strategic alliances supporting dosage form development, clinical research, and manufacturing.

IRIX ensures compliance with all regulatory and quality requirements.

Operating as an extension of the internal resources, IRIX offers sharp process solutions for an accelerated time to market at a very competitive cost.